Active behaviours produced by antidepressants and opioids in the mouse tail suspension test

International Journal of Neuropsychopharmacology

Volumn 16, Issue 1, 2013, Pages 151-162

  Berrocoso, Esther ^a,b   Ikeda, Kazutaka ^c   Sora, Ichiro ^d   Uhl, George R ^e   Sánchez Blázquez, Pilar ^b,f   Mico, Juan Antonio ^a,b  

^a UNIVERSITY OF CÁDIZ   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^f INSTITUTO CAJAL   (Spain)

Author keywords

opioid knockout; Antidepressants; behavioural despair; opioids; tail suspension test

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CODEINE; DESIPRAMINE; DULOXETINE; IMIPRAMINE; LEVORPHANOL; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE; TRAMADOL; VENLAFAXINE;

ADRENERGIC TRANSMISSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CURLING; DRUG EFFECT; EXPERIMENTAL TEST; FEMALE; GENOTYPE; HOMOZYGOSITY; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; SWINGING; TAIL SUSPENSION TEST; TEST RETEST RELIABILITY;

ANALGESICS, OPIOID; ANIMALS; ANTIDEPRESSIVE AGENTS; FEMALE; HINDLIMB SUSPENSION; IMMOBILITY RESPONSE, TONIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, OPIOID, MU;

EID: 84871479775     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001842     Document Type: Article

References (48)

1. Beique JC, Lavoie N, de Montigny C, Debonnel G (1998). Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters. European Journal of Pharmacology 349, 129-132.
2. Benbouzid M, Gaveriaux-Ruff C, Yalcin I, Waltisperger E, et al. (2008). Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biological Psychiatry 63, 633-636.
3. Berrocoso E, Mico JA (2009a). Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. International Journal of Neuropsychopharmacology 12, 1033-1044.
4. Berrocoso E, Mico JA (2009b). Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice. International Journal of Neuropsychopharmacology 12, 61-71.
5. Berrocoso E, Rojas-Corrales MO,Mico JA (2006). Differential role of 5-HT1A and 5-HT1B receptors on the antinociceptive and antidepressant effect of tramadol in mice. Psychopharmacology (Berlin) 188, 111-118.
6. Berrocoso E, Sanchez-Blazquez P, Garzon J, Mico JA (2009). Opiates as antidepressants. Current Pharmaceutical Design 15, 1612-1622.
7. Besson A, Privat AM, Eschalier A, Fialip J (1996). Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats. Psychopharmacology (Berlin) 123, 71-78.
8. Bilbey DL, Salem H, Grossman MH (1960). The anatomical basis of the Straub phenomenon. British Journal of Pharmacology and Chemotherapy 15, 540-543.
9. Bodkin JA, Zornberg GL, Lukas SE, Cole JO (1995). Buprenorphine treatment of refractory depression. Journal of Clinical Psychopharmacology 15, 49-57.
10. Bravo L, Berrocoso E, Mico JA (2009). Animal models in psychiatry: conceptualization and preclinical models of depression. European Journal of Psychiatry 23 (Suppl.), 111-122.
11. Chermat R, Thierry B, Mico JA, Steru L, et al. (1986). Adaptation of the tail suspension test to the rat. Journal of Pharmacology 17, 348-350.
12. Codd EE, Shank RP, Schupsky JJ, Raffa RB (1995). Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception. Journal of Pharmacology and Experimental Therapeutics 274, 1263-1270.
13. Cryan JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23, 238-245.
14. Cryan JF, Mombereau C, Vassout A (2005a). The tail suspension test as a model for assessing antidepressant activity : review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews 29, 571-625.
15. Cryan JF, Valentino RJ, Lucki I (2005b). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioural Reviews 29, 547-569.
16. Detke MJ, Rickels M, Lucki I (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berlin) 121, 66-72.
17. Fanelli J, Montgomery C (1998). Use of the analgesic tramadol in antidepressant potentiation. Psychopharmacology Bulletin 32, 442.
18. Fichna J, Janecka A, Piestrzeniewicz M, Costentin J, et al. (2007). Antidepressant-like effect of endomorphin-1 and endomorphin-2 in mice. Neuropsychopharmacology 32, 813-821.
19. Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, et al. (2009). The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides 43, 341-353.
20. Ide S, Sora I, Ikeda K, Minami M, et al. (2010). Reduced emotional and corticosterone responses to stress in mu-opioid receptor knockout mice. Neuropharmacology 58, 241-247.
21. Jutkiewicz EM (2006). The antidepressant-like effects of delta-opioid receptor agonists. Molecular Interventions 6, 162-169.
22. Kennedy SE, Koeppe RA, Young EA, Zubieta JK (2006). Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. Archives of General Psychiatry 63, 1199-1208.
23. Kraepelin E (1901). Einführung in Die Psychiatrische Klinik. Leipzig: Ambrosius Barth-Verlag.
24. Liu X, Gershenfeld HK (2001). Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice. Biological Psychiatry 49, 575-581.
25. Lucki I, Dalvi A, Mayorga AJ (2001). Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berlin) 155, 315-322.
26. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, et al. (2003). Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. Journal of Pharmacology and Experimental Therapeutics 305, 323-330.
27. Narita M, Suzuki T, Misawa M, Nagase H (1993). Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice. Psychopharmacology (Berlin) 110, 254-256.
28. Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997). Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. Journal of Pharmacology and Experimental Therapeutics 283, 1305-1322.
29. Petit-Demouliere B, Chenu F, Bourin M (2005). Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berlin) 177, 245-255.
30. Pliakas AM, Carlson RR, Neve RL, Konradi C, et al. (2001). Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. Journal of Neuroscience 21, 7397-7403.
31. Raffa RB, Friderichs E, Reimann W, Shank RP, et al. (1992). Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. Journal of Pharmacology and Experimental Therapeutics 260, 275-285.
32. Raffa RB, Friderichs E, Reimann W, Shank RP, et al. (1993). Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. Journal of Pharmacology and Experimental Therapeutics 267, 331-340.
33. Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2002). Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sciences 72, 143-152.
34. Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2004). Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. Journal of Psychopharmacology 18, 404-411.
35. Rojas-Corrales MO, Gibert-Rahola J, Mico JA (1998). Tramadol induces antidepressant-type effects in mice. Life Sciences 63, PL175-PL180.
36. Shapira NA, Verduin ML, DeGraw JD (2001). Treatment of refractory major depression with tramadol monotherapy. Journal of Clinical Psychiatry 62, 205-206.
37. Shirayama Y, Ishida H, Iwata M, Hazama GI, et al. (2004). Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. Journal of Neurochemistry 90, 1258-1268.
38. Sora I, Elmer G, Funada M, Pieper J, et al. (2001). Mu opiate receptor gene dose effects on different morphine actions : evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology 25, 41-54.
39. Spencer C (2000). The efficacy of intramuscular tramadol as a rapid-onset antidepressant. Australian and New Zealand Journal of Psychiatry 34, 1032-1033.
40. Steru L, Chermat R, Thierry B, Mico JA, et al. (1987). The automated tail suspension test : a computerized device which differentiates psychotropic drugs. Progress in Neuropsychopharmacology and Biological Psychiatry 11, 659-671.
41. Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test : a new method for screening antidepressants in mice. Psychopharmacology (Berlin) 85, 367-370.
42. Stoll AL, Rueter S (1999). Treatment augmentation with opiates in severe and refractory major depression. American Journal of Psychiatry 156, 2017.
43. Tejedor-Real P, Mico JA, Maldonado R, Roques BP, et al. (1993). Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat. Biological Psychiatry 34, 100-107.
44. Tejedor-Real P, Mico JA, Maldonado R, Roques BP, et al. (1995). Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacology Biochemistry and Behavior 52, 145-152.
45. Tejedor-Real P, Mico JA, Smadja C, Maldonado R, et al. (1998). Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. European Journal of Pharmacology 354, 1-7.
46. Torregrossa MM, Folk JE, Rice KC, Watson SJ, et al. (2005). Chronic administration of the delta opioid receptor agonist (+)BW373U86 and antidepressants on behavior in the forced swim test and BDNF mRNA expression in rats. Psychopharmacology (Berlin) 183, 31-40.
47. Torregrossa MM, Jutkiewicz EM, Mosberg HI, Balboni G, et al. (2006). Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Research 1069, 172-181.
48. Yalcin I, Aksu F, Bodard S, Chalon S, et al. (2007). Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system. Behavioural Pharmacology 18, 623-631.